In the second session of the NHS Innovation and Life Sciences Commission Dementia Programme, the panellists outline their vision for the future of Dementia Treatment and Care.
In a recent session focused on treatment and care for patients with dementia, experts shared their visions for the future. The panel included Chief Executive at Alzheimer’s Research UK, Hilary Evans, Director of the Dementia Research Centre, and Group Leader at UK DRI at UCL Professor Nick Fox and Professor of Applied Dementia Research at Norwich Medical School, Professor Michael Hornberger. They discussed advancements in technology, raising awareness, early detection, research participation, and the need for comprehensive and person-centred approaches to improve the lives of individuals with dementia and their families.
Treatment and Care for Dementia in Ten Years
During the session, the panellists were asked about their vision for the state of diagnostics, treatment, and care in ten years’ time. Professor Hornberger expressed his belief that blood tests would likely be available, emphasising the importance of early identification and implementing treatments. He also highlighted the significance of raising awareness about preventing dementia and reducing the risk.
Evans, representing Alzheimer’s Research UK, envisioned a future where people in early and midlife understand the measures, they can take to mitigate their chances of developing dementia. She stressed the importance of early detection, identifying higher-risk individuals, and improving the infrastructure for clinical trials in the UK.
Professor Fox highlighted the need for a fundamental shift in the diagnostic process for dementia, similar to cancer diagnoses. He emphasised the importance of making specific diagnoses, allowing for targeted treatments, and understanding the underlying causes. Nick also called for a re-evaluation of end-of-life care and empowering individuals to be involved in decisions regarding their care and treatment preferences.
Barriers and Solutions
The panellists also discussed the barriers to implementing advancements in dementia treatment and care. They highlighted the need for increased funding, additional training, and innovative approaches to multidisciplinary teams. They also emphasised the importance of regulation, integration, and strategies to accelerate the adoption and implementation of new advancements.
Involving Informal Carers and Patients
The panellists recognised the importance of involving informal carers in care pathways and addressing their confusion and challenges in navigating the healthcare system. They emphasised the need to support informal carers to prevent emergency crisis admissions and reduce reliance on residential care. They also highlighted the significance of providing well-being, support, and knowledge to individuals to help them navigate the system and access necessary help.
Raising Awareness and Changing Perceptions
The panellists discussed the strategies required to raise awareness, educate, and empower people about dementia. They emphasised the progress made in the last ten years in breaking down stigma and encouraging conversations around dementia. They highlighted the impact of campaigns, public figures, and celebrities sharing their experiences with dementia, leading to increased awareness, and understanding.
Final Thoughts
The future of dementia treatment and care looks promising, thanks to the valuable insights shared by experts in the recent inquiry session. As we look forward to the next decade, their visions paint a picture of hope and progress in the fight against dementia.
The prospect of blood tests for early identification of dementia offers great potential for timely interventions, and it is heartening to see a collective focus on raising awareness and empowering individuals to take proactive measures to reduce their risk. The shift towards specific diagnoses and targeted treatments, akin to cancer care, holds the promise of improving outcomes and understanding the complex underlying causes of dementia.
However, these visions are not without challenges. The need for increased funding, training, and innovative approaches to interdisciplinary care highlights the importance of investing in the future of dementia research and treatment. The focus on regulation, integration, and fast-tracking the adoption of advancements underscores the urgency of translating scientific progress into tangible benefits for patients and their families.
A standout aspect of the discussion was the recognition of the crucial role informal carers play in the lives of those with dementia. By involving them in care pathways and providing support and knowledge, we can create a stronger support network that reduces crisis admissions and fosters a more holistic approach to dementia care.
Furthermore, the efforts to raise awareness and change perceptions about dementia are yielding positive results. The reduction of stigma and the encouragement of open conversations about the condition have contributed to increased public understanding and support.
As we move forward, it is clear that collaboration, compassion, and commitment will be paramount in realising these visions. By embracing the advancements in technology, promoting research participation, and prioritising person-centred approaches, we can create a future where dementia is more manageable, and individuals affected by the condition can lead fulfilling lives.
By continuing to break down barriers, involving informal carers, and raising awareness, we can collectively build a more compassionate and supportive world for individuals living with dementia and their families. Together, we can turn these visions into a reality and make a lasting impact on the lives of millions affected by this condition.
About the Dementia Programme
To find out more about the Dementia Commission and the future inquiry session, please contact team@curiauk.com or visit www.curiauk.com and read more through the NHS Innovation and Life Sciences Commission microsite.
For the full video watch here: